DailyDoctor Archive Specialties Get app
Back to the 5 October 2026 edition

Practice changer · 05 of 05

Survival after below-knee amputation in diabetes has not improved

Treat a below-knee amputation as a marker of high mortality and future events: intensify cardiovascular risk management and protect the contralateral limb.

Design
National population study, mortality-linked Hospital Episode Statistics, Kaplan-Meier and Cox models
Population
25,176 people with diabetes undergoing 28,232 below-knee amputations in England
Primary outcome
All-cause mortality after below-knee amputation
Effect
Mortality 23.5% at 1 year, 60.0% at 5 years, 82.3% at 10 years; no improvement since 2012

An England population study tracked 25,176 people with diabetes through 28,232 below-knee amputations, linking the procedures to mortality records over 25 years.

All-cause mortality was 23.5% at one year, 60.0% at five years and 82.3% at ten, with no improvement since 2012. A contralateral amputation reached 6.43% by five years. Older age, greater comorbidity and female sex marked the highest-risk patients. These are counselling numbers: a major amputation signals advanced systemic disease, and most of the later deaths are cardiovascular rather than surgical.

The practice change is upstream. The stark survival should sharpen foot-risk stratification, prompt earlier vascular and multidisciplinary referral for the threatened limb, and drive aggressive cardiovascular risk management once an amputation has happened, because the contralateral limb and the heart are the next events. It also reframes what the operation means for patients and families.

  • One-year mortality after below-knee amputation was 23.5%, rising to 82.3% at ten years.
  • Survival has not improved since 2012 despite modern care.
  • A second, contralateral amputation occurred in 6.43% by five years.
  • Treat an amputation as a marker of advanced systemic disease; most later deaths are cardiovascular.
  • Intensify cardiovascular risk management and protect the remaining limb after any major amputation.

Why it matters

It shows the operation is a sentinel event for systemic disease, not an endpoint in itself.

Don't overread it

This is observational and describes who dies, not why a given patient will; it cannot attribute the deaths to the amputation itself.

The statistics, in plain English

These are absolute survival rates from a Kaplan-Meier analysis, not a treatment comparison; the hazard ratios (such as older age HR 1.62) rank risk within the amputation group rather than against people without an amputation.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

obesityglp1type2cgminsulintype1pediatricneuropathyretinopathy

Tomorrow morning, before your first patient

One edition a day for diabetes & endocrinology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app